Skip to content

Clinical study on circulating exosomal miRNA-based exploration of interstitial lung and kidney qi deficiency-type interstitial lung disease treated by salt-spaced governor moxibustion

Clinical study on circulating exosomal miRNA-based exploration of interstitial lung and kidney qi deficiency-type interstitial lung disease treated by salt-spaced governor moxibustion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096380
Enrollment
Unknown
Registered
2025-01-22
Start date
2023-09-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung disease

Interventions

intervention group:polysyllabic moxibustion (TCM)
control group:None

Sponsors

Shenzhen Hospital of Integrative Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria; (2) Patients aged 40-75 years old with elementary school education or above; (3) Patients whose condition is in a stable period and without other serious complications; (4) Informed about the trial and voluntarily participated in signing the informed consent; (5) They can take care of themselves, and have normal cognitive ability and verbal communication ability.

Exclusion criteria

Exclusion criteria: (1) Those who have serious complications secondary to cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems; (2) Those suffering from acute respiratory distress syndrome, bronchial asthma, lung cancer, tuberculosis bronchiectasis and cardiogenic pulmonary edema; (3) Those who are allergic to salt and moxa; (4) Women who are menstruating, pregnant or breastfeeding. (5) Those with communication disorders, mental anomalies, personality disorders, or intellectual or thinking abnormalities who are unable to cooperate; (6) Those who are participating in other clinical experiments.

Design outcomes

Primary

MeasureTime frame
lung function;CT scan of the lungs;Chinese Medicine Symptom Score;

Secondary

MeasureTime frame
quality of life;

Countries

China

Contacts

Public ContactLiu Hanjiao

Shenzhen Hospital of Integrative Medicine

szajhlb3667@sina.com+86 136 0303 5142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026